BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 35298614)

  • 1. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
    Cadrin-Tourigny J; Bosman LP; Wang W; Tadros R; Bhonsale A; Bourfiss M; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; Van der Heijden JF; Tandri H; Jongbloed JDH; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Circ Arrhythm Electrophysiol; 2021 Jan; 14(1):e008509. PubMed ID: 33296238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2022 Aug; 43(32):e1-e9. PubMed ID: 35441664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Platonov PG; Haugaa KH; Bundgaard H; Svensson A; Gilljam T; Hansen J; Madsen T; Holst AG; Carlson J; Lie ØH; Kvistholm Jensen M; Edvardsen T; Jensen HK; Svendsen JH
    Am J Cardiol; 2019 Apr; 123(7):1156-1162. PubMed ID: 30678832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Bosman LP; Nozza A; Wang W; Tadros R; Bhonsale A; Bourfiss M; Fortier A; Lie ØH; Saguner AM; Svensson A; Andorin A; Tichnell C; Murray B; Zeppenfeld K; van den Berg MP; Asselbergs FW; Wilde AAM; Krahn AD; Talajic M; Rivard L; Chelko S; Zimmerman SL; Kamel IR; Crosson JE; Judge DP; Yap SC; van der Heijden JF; Tandri H; Jongbloed JDH; Guertin MC; van Tintelen JP; Platonov PG; Duru F; Haugaa KH; Khairy P; Hauer RNW; Calkins H; Te Riele ASJM; James CA
    Eur Heart J; 2019 Jun; 40(23):1850-1858. PubMed ID: 30915475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
    Woźniak O; Borowiec K; Konka M; Cicha-Mikołajczyk A; Przybylski A; Szumowski Ł; Hoffman P; Poślednik K; Biernacka EK
    Heart; 2022 Jan; 108(1):22-28. PubMed ID: 33674353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
    Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud JB; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C; Tandri H; Zeppenfeld K; Wilde AAM; Davies B; Seifer C; Roberts JD; Healey JS; MacIntyre C; Alqarawi W; Tadros R; Cutler MJ; Targetti M; Calò L; Vitali F; Bertini M; Compagnucci P; Casella M; Dello Russo A; Cappelletto C; De Luca A; Stolfo D; Duru F; Jensen HK; Svensson A; Dahlberg P; Hasselberg NE; Di Marco A; Jordà P; Arbelo E; Moreno Weidmann Z; Borowiec K; Delinière A; Biernacka EK; van Tintelen JP; Platonov PG; Olivotto I; Saguner AM; Haugaa KH; Cox M; Tondo C; Merlo M; Krahn AD; Te Riele ASJM; Wu KC; Calkins H; James CA; Cadrin-Tourigny J
    Eur Heart J; 2024 Feb; 45(7):538-548. PubMed ID: 38195003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification for ventricular arrhythmias and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: an update.
    Cadrin-Tourigny J; Bosman LP; Tadros R; Talajic M; Rivard L; James CA; Khairy P
    Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):645-651. PubMed ID: 31422711
    [No Abstract]   [Full Text] [Related]  

  • 14. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors.
    Chung FP; Li HR; Chong E; Pan CH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Lin WY; Shaw KP; Chen SA
    Heart Rhythm; 2013 Dec; 10(12):1859-66. PubMed ID: 24080066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators.
    Wang W; Cadrin-Tourigny J; Bhonsale A; Tichnell C; Murray B; Monfredi O; Chrispin J; Crosson J; Tandri H; James CA; Calkins H
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1396-1402. PubMed ID: 29894017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
    Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features, Genetic Findings, and Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy: Data From a Brazilian Cohort.
    Olivetti NQS; Sacilotto L; Wulkan F; D'Arezzo Pessente G; Lombardi Peres de Carvalho M; Moleta D; Tessariol Hachul D; Veronese P; Hardy C; Pisani C; Wu TC; Vieira MLC; de França LA; de Souza Freitas M; Rochitte CE; Bueno SC; Bastos Lovisi V; Krieger JE; Scanavacca M; da Costa Pereira A; da Costa Darrieux F
    Circ Arrhythm Electrophysiol; 2023 Feb; 16(2):e011391. PubMed ID: 36720007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.